Tuberculosis Trial, Recruiting NCT05426720 Sponsor: Peking University Third Hospital Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT05426720
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are male and between 25 and 60 years old
  • You have recently been diagnosed with active tuberculosis (TB) affecting the lungs

Who may not be able to join:

  • Your sputum (mucus/phlegm) test or TB lab culture came back positive
  • You are HIV-positive
  • You have a type of TB that does not respond to standard TB medicines (multidrug-resistant TB)
  • You have been diagnosed with cancer (such as lung cancer) or a serious heart or brain/blood vessel condition
  • You are unable or unwilling to complete breathing/lung function tests as required by the study
  • Your TB has not caused damage to the lung tissue itself — for example, if your TB only affects the lining around the lungs (such as tuberculous pleurisy) rather than the lungs directly (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yongchang Sun, MD, Respiratory and Critical Care Department, Peking University Third Hospital

Phone: 13522708870

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Peking University Third Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2022
Est. completion
31 December 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

lung function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov